ÂÜÀòÂÒÂ×

David Sable is an experienced portfolio manager at Life Sciences since February 2005 and an instructor in "Entrepreneurship in Biotechnology" at Columbia University since January 2011. In addition to academic responsibilities, David serves as a director at Hamilton Thorne, Inc., AutoIVF, and Celmatix, and holds roles as board observer and SAB member at TMRW Life Sciences, Inc. Advisory board memberships include Conceivable Life Sciences and Evvy, while past directorship includes MedAnswers and Ohana Biosciences, Inc. David Sable obtained an MD from the University of Pennsylvania School of Medicine and a BS in Economics from The Wharton School.